CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
View All Press
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.
Continue